-
About clinical trials
Learn more -
Participating in a trial
Learn more -
Find a trial
Learn more
Research at Icon Cancer Centre
Icon Cancer Centre has over 35 years’ experience in cancer research and now operates the largest private cancer clinical trials program in Australia. We believe patients across our centres deserve the opportunity to access clinical trials and the hope that they offer.
To find out more about the research that Icon is participating in, as well as our team and achievements during 2023, please read the 2023 Icon Research Annual Report.
Bring hope to people living with cancer
Icon’s cancer foundation funds our innovative cancer research program and clinical trials. Give hope to patients living with cancer and shape a brighter future for generations to come.
Research excellence, independently recognised
In 2024, Icon Cancer Centre Research became the first Australian organisation to achieve internationally recognised accreditation for both clinical research site quality and workforce excellence. In 2026, we advanced this achievement through renewed certification and Gold-level accreditation, reinforcing our commitment to delivering high-quality clinical research and better outcomes for patients.
Clinical trials offered at Icon
At Icon, our dedicated research program enables our patients to access new and emerging advances in cancer treatment, giving new hope and opportunities to patients and their families.
We run trials across various tumour types and haematological conditions, including chemotherapy, immunotherapy and radiation therapy trials. Icon also offer trials that aren’t directly connected to a treatment technique, but are focused on wellbeing and improving quality of life for our patients.
By providing access to a wide range of clinical trials across a multitude of cancer types, Icon helps to contribute to breakthroughs and advancements in cancer treatments for the benefit of current and future patients.
